IPC STATEMENT
on SARS-CoV-2 Vaccines and Psoriasis
Six key take-aways that physicians and other healthcare practitioners should consider when administering the SARS-CoV-2 vaccine to psoriasis patients.
READ FULL STATEMENT
The National Psoriasis Foundation
COVID-19 Task Force Guidance Statements
Twenty-five key recommendations for the management of patients with psoriatic disease during the COVID-19 pandemic.
READ STATEMENTS